Nehal N. Mehta

Mehta was born in Mumbai; as a one-year-old, he moved to the United States. Mehta attended the George Washington University's 7-year biomedical program and received his Bachelor of Arts in 1997 with Honors and Doctor of Medicine degree in 2001 with Distinction. He spent time in 1997 studying Biochemistry at Oxford University, United Kingdom before starting medical school. He then completed a residency in internal medicine, fellowship in cardiovascular diseases, nuclear cardiology, and a post-doctoral fellowship in genetic epidemiology at the Hospital of the University of Pennsylvania where he joined in 2007 as the Director of the Inflammatory Risk in Preventive Cardiology. Initially, Mehta focused on the role of inflammation in obesity and performed studies demonstrating that acute inflammation led to adipose inflammation. Then in 2009, he extended these findings by collaborating with Dr. Joel Gelfand to understand why psoriasis, an inflammatory skin disease increased risk for heart attack. To characterize this link, Mehta received the first Lasker Clinical Scholar Award which moved his program from the University of Pennsylvania to the NIH. In 2012, the Albert and Mary Lasker Foundation and the NIH named him the inaugural Lasker Investigator, enabling Mehta to create a laboratory focusing on the role of inflammation in cardiometabolic diseases at the NIH.

Nehal N. Mehta, (born November 30, 1975) is an American cardiologist at the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, Maryland where he studies the role of innate immunity and inflammation in the development of cardiovascular and metabolic diseases.